NucleoSpin Blood L / XL

Additional information

Brand

Applications

  • DNA from whole blood (human or animal blood, fresh or frozen)
  • DNA from whole blood treated with citrate, EDTA, heparin, CPDA
  • DNA from serum, plasma, buffy coat, platelets, body fluids (e.g., amniotic fluid)
  • DNA from cultured cells
  • Typical downstream applications: PCR, Southern blotting, enzymatic reactions

Features

  • Ready-to-use DNA in less than 60 min
  • Complete removal of PCR inhibitors
  • Suitable for whole blood, treated with citrate, EDTA, heparin, CPDA
  • Consistently high DNA yields

Specifications

  • Technology: Silica membrane technology

NucleoSpin® Blood L

  • Processing: Centrifugation*
  • Sample material: Blood (0.2–2 mL), human / animal cells (2 x 10⁷)
  • Fragment size: 200 bp–approx. 50 kbp
  • Typical yield: 40–60 μg (2 mL blood)
  • Elution volume: 120–200 μL
  • Binding capacity: 250 μg
  • Processing time: 60 min/prep

NucleoSpin® Blood XL

  • Processing: Centrifugation*
  • Sample material: Blood (2–10 mL), human / animal cells (10⁸)
  • Fragment size: 200 bp–approx. 50 kbp
  • Typical yield: 200–300 μg (10 mL blood)
  • Elution volume: 600–2000 μL
  • Binding capacity: 700 μg
  • Processing time: 60 min/prep